50
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluation

Taribavirin for the treatment of chronic hepatitis C

, &
Pages 3243-3249 | Published online: 28 Nov 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Josep Quer, Maria Buti, Maria Cubero, Jaume Guardia, Rafael Esteban & Juan Ignacio Esteban. (2010) New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents. Infection and Drug Resistance 3, pages 133-145.
Read now

Articles from other publishers (9)

Wendong Jia, Yusheng Ouyang, Shanyu Zhang, Xiaoyu Du, Panke Zhang & Shuo Huang. (2023) Nanopore Signatures of Nucleoside Drugs. Nano Letters 23:20, pages 9437-9444.
Crossref
Rahul Kumar, Sahil Mishra, Shreya & Sushil K. Maurya. (2021) Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses. RSC Medicinal Chemistry 12:3, pages 306-320.
Crossref
Haiyan Guo, Shuai Sun, Zhenhua Yang, Xing Tang & Yanjiao Wang. (2015) Strategies for ribavirin prodrugs and delivery systems for reducing the side-effect hemolysis and enhancing their therapeutic effect. Journal of Controlled Release 209, pages 27-36.
Crossref
Yanping Li, Zonggen Peng, Lanhu Hao, Zhouyi Wu, Yanping Zhu, Laixing Hu, Jiandong Jiang & Zhuorong Li. (2013) Synthesis of novel substituted N-aryl benzamides as hA3G stabilizers and their inhibitory activities against hepatitis C virus replication. Acta Pharmaceutica Sinica B 3:5, pages 312-321.
Crossref
Christopher P Farrell, Giancarlo Mercogliano, Victor J Navarro & Simona Rossi. (2011) Taribavirin: potential future in the treatment of hepatitis C. Future Virology 6:2, pages 147-155.
Crossref
McKenzie C. Ferguson. (2012) Current Therapies for Chronic Hepatitis C. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:1, pages 92-111.
Crossref
Sonja B Braun-SandMatthew Peetz. (2010) Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics. Future Medicinal Chemistry 2:1, pages 81-92.
Crossref
Ricardo Jiménez-Méndez & Gilberto Castañeda-Hernández. (2010) Characteristics of hepatitis C treatment with pegylated interferons and ribavirin. Annals of Hepatology 9, pages S61-S64.
Crossref
FRED Y. AOKI, FREDERICK G. HAYDEN & RAPHAEL DOLIN. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 565 610 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.